Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism

Neurobiology of Disease

Volumn 80, Issue , 2015, Pages 42-53

  Olde Loohuis, N F M ^a   Kole, K ^a   Glennon, J C ^a   Karel, P ^a   Van der Borg, G ^a   Van Gemert, Y ^a   Van den Bosch, D ^a   Meinhardt, J ^a   Kos, A ^a   Shahabipour, F ^a   Tiesinga, P ^a   van Bokhoven, H ^a,c   Martens, G J M ^a   Kaplan, B B ^b   Homberg, J R ^a   Aschrafi, A ^a  

^a RADBOUD UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amygdala; Autism spectrum disorder; Gene networks; MicroRNA; Neurodevelopmental disorder; Rat model of autism; Valproic acid

Indexed keywords

MICRORNA; MICRORNA 181C; MICRORNA 30D; UNCLASSIFIED DRUG; MIRN181 MICRORNA, RAT; MIRN30 MICRORNA, RAT; TRANSCRIPTOME; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BINDING SITE; BRAIN REGION; BRAIN SIZE; CELL DENSITY; CELL DIFFERENTIATION; HEMISPHERE; HYPOTHALAMUS; MOTOR PERFORMANCE; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; SOCIAL BEHAVIOR; SWIMMING; SYNAPSE; SYNAPTOGENESIS; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; GENETICS; METABOLISM; PATHOLOGY;

AMYGDALA; ANIMALS; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; MICRORNAS; NEURONS; RATS; SOCIAL BEHAVIOR; TRANSCRIPTOME; VALPROIC ACID;

EID: 84930216280     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.05.006     Document Type: Article

References (74)

1. Abu-Elneel K., et al. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008, 9:153-161.
2. Alberi L., et al. Activity-induced Notch signaling in neurons requires Arc/Arg3.1 and is essential for synaptic plasticity in hippocampal networks. Neuron 2011, 69:437-444.
3. Aschrafi A., et al. The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain 8. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:2180-2185.
4. Aydin H., et al. A convenient and general expression platform for the production of secreted proteins from human cells. J. Vis. Exp. 2012, 65. pii: 4041.
5. Aylward E.H., et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 1999, 53:2145-2150.
6. Bagga S., et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005, 122:553-563.
7. Bellani M., et al. Brain anatomy of autism spectrum disorders II. Focus on amygdala. Epidemiol. Psychiatr. Sci. 2013, 22:309-312.
8. Beveridge N.J., Cairns M.J. MicroRNA dysregulation in schizophrenia. Neurobiol. Dis. 2012, 46:263-271.
9. Bringas M.E., et al. Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Neuroscience 2013, 241:170-187.
10. Chen G., et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J. Neurochem. 1999, 72:879-882.
11. Chen Y., et al. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12011-12016.
12. Comery T.A., et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5401-5404.
13. Cools A.R., et al. Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res. Bull. 1990, 24:49-69.
14. Davis T.H., et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 2008, 28:4322-4330.
15. De Preter K., et al. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod. Pathol. 2002, 15:159-166.
16. Dietz K.C., Casaccia P. HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacol. Res. 2010, 62:11-17.
17. Dumanis S.B., et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J. Neurosci. 2009, 29:15317-15322.
18. Dumanis S.B., et al. ApoE receptor 2 regulates synapse and dendritic spine formation. PLoS One 2011, 6:e17203.
19. Ebert M.S., et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4:721-726.
20. Edalatmanesh M.A., et al. Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism. Brain Res. 2013, 1526:15-25.
21. Fassio A., et al. SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum. Mol. Genet. 2011, 20:2297-2307.
22. Gentner B., et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 2009, 6:63-66.
23. Gentner D., et al. Reviving inert knowledge: analogical abstraction supports relational retrieval of past events. Cogn. Sci. 2009, 33:1343-1382.
24. Ghahramani Seno M.M., et al. Gene and miRNA expression profiles in autism spectrum disorders. Brain Res. 2011, 1380:85-97.
25. Go H.S., et al. Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3beta/beta-catenin pathway. Neuropharmacology 2012, 63:1028-1041.
26. Gogos J.A., et al. MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res. 2010, 1338:78-88.
27. Hafner M., et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008, 44:3-12.
28. Helwak A., et al. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153:654-665.
29. Ingram J.L., et al. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 2000, 22:319-324.
30. Kaplan B.B., et al. MicroRNAs in the axon and presynaptic nerve terminal. Front. Cell. Neurosci. 2013, 7:126.
31. Kim J.E., et al. Laterobasal amygdalar enlargement in 6- to 7-year-old children with autism spectrum disorder. Arch. Gen. Psychiatry 2010, 67:1187-1197.
32. Lee S., et al. Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging. Cell. Mol. Life Sci. 2011, 68:325-336.
33. Lim L.P., et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
34. Lorenzo A., et al. Amygdala neurons in vitro: neurite growth and effects of estradiol. J. Neurosci. Res. 1992, 33:418-435.
35. Markram H., et al. The intense world syndrome-an alternative hypothesis for autism. Front. Neurosci. 2007, 1:77-96.
36. Markram K., et al. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008, 33:901-912.
37. Mintz M., et al. Sharing of the home base: a social test in rats. Behav. Pharmacol. 2005, 16:227-236.
38. Muller R.A. The study of autism as a distributed disorder. Ment. Retard. Dev. Disabil. Res. Rev. 2007, 13:85-95.
39. Nadif Kasri N., et al. Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery. Neuron 2011, 72:300-315.
40. Niesink R.J., Van Ree J.M. Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats. Neuropharmacology 1989, 28:411-418.
41. Nishiyama H., et al. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:4037-4042.
42. Nordahl C.W., et al. Increased rate of amygdala growth in children aged 2 to 4years with autism spectrum disorders: a longitudinal study. Arch. Gen. Psychiatry 2012, 69:53-61.
43. Olde Loohuis N.F., et al. MicroRNA networks direct neuronal development and plasticity. Cell. Mol. Life Sci. 2012, 69:89-102.
44. Parikshak N.N., et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 2013, 155:1008-1021.
45. Park C.S., Tang S.J. Regulation of microRNA expression by induction of bidirectional synaptic plasticity. J. Mol. Neurosci. 2009, 38:50-56.
46. Rasalam A.D., et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev. Med. Child Neurol. 2005, 47:551-555.
47. Redmond L., et al. Nuclear Notch1 signaling and the regulation of dendritic development. Nat. Neurosci. 2000, 3:30-40.
48. Reeves R.H., et al. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:5359-5363.
49. Rodier P.M., et al. Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 1997, 11:417-422.
50. Rodriguez Manzanares P.A., et al. Previous stress facilitates fear memory, attenuates GABAergic inhibition, and increases synaptic plasticity in the rat basolateral amygdala. J. Neurosci. 2005, 25:8725-8734.
51. Saba R., et al. Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons. Mol. Cell. Biol. 2012, 32:619-632.
52. Sarachana T., et al. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med. 2010, 2:23.
53. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
54. Schmittgen T.D., et al. Real-time PCR quantification of precursor and mature microRNA. Methods 2008, 44:31-38.
55. Schneider T., Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30:80-89.
56. Schneider T., et al. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 2006, 31:36-46.
57. Schouten M., et al. MicroRNAs and the regulation of neuronal plasticity under stress conditions. Neuroscience 2013, 241:188-205.
58. Schumann C.M., Amaral D.G. Stereological analysis of amygdala neuron number in autism. J. Neurosci. 2006, 26:7674-7679.
59. Schumann C.M., et al. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J. Neurosci. 2004, 24:6392-6401.
60. Schumann C.M., et al. Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol. Psychiatry 2009, 66:942-949.
61. Sempere L.F., et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004, 5:R13.
62. Shamir A., et al. The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J. Neurosci. 2012, 32:2988-2997.
63. Silva G.T., et al. Enhanced long-term microcircuit plasticity in the valproic acid animal model of autism. Front. Synaptic Neurosci. 2009, 1:1.
64. Singh V., et al. Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia. Neuroscience 2014, 265:147-157.
65. Snow W.M., et al. Altered morphology of motor cortex neurons in the VPA rat model of autism. Dev. Psychobiol. 2008, 50:633-639.
66. Sosa-Diaz N., et al. Prefrontal cortex, hippocampus, and basolateral amygdala plasticity in a rat model of autism spectrum. Synapse 2014, 68:468-473.
67. Tabuchi K., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
68. Valles A., et al. MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia. J. Psychiatry Neurosci. 2014, 39:130269.
69. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu. Rev. Genet. 2011, 45:81-104.
70. Wang W.X., et al. Individual microRNAs (miRNAs) display distinct mRNA targeting "rules". RNA Biol. 2010, 7:373-380.
71. Willemsen M.H., et al. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J. Med. Genet. 2011, 48:810-818.
72. Yildirim E., et al. Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus. Neurosci. Lett. 2003, 345:141-143.
73. Zhang C., et al. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J. Neurosci. 2009, 29:10843-10854.
74. Zhou R., et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009, 34:1395-1405.